Hillary Bracken1. 1. Gynuity Health Projects, New York, NY 10010, USA. hbracken@gynuity.org
Abstract
OBJECTIVE: To assess the efficacy and acceptability of home administration of misoprostol for early medical abortion in Indian family planning clinics. METHODS: In this prospective cohort study, consenting pregnant women (n=599) with amenorrhea of 8 weeks or less seeking termination of pregnancy received 200mg of oral mifepristone followed 48 hours later with 400microg of oral misoprostol, administered either at home or at the clinic. RESULTS: Almost all women (88.4%) chose to take misoprostol home. There was no statistical difference in success rates between home and clinic users (89.0% vs 92.4%, Pearson chi(2)=0.7; P=0.395). Most women in both the home (90.7%) and clinic (92.3%) groups were satisfied or very satisfied with the procedure. CONCLUSION: Home administration of misoprostol is safe and feasible for introduction into medical abortion services in India.
OBJECTIVE: To assess the efficacy and acceptability of home administration of misoprostol for early medical abortion in Indian family planning clinics. METHODS: In this prospective cohort study, consenting pregnant women (n=599) with amenorrhea of 8 weeks or less seeking termination of pregnancy received 200mg of oral mifepristone followed 48 hours later with 400microg of oral misoprostol, administered either at home or at the clinic. RESULTS: Almost all women (88.4%) chose to take misoprostol home. There was no statistical difference in success rates between home and clinic users (89.0% vs 92.4%, Pearson chi(2)=0.7; P=0.395). Most women in both the home (90.7%) and clinic (92.3%) groups were satisfied or very satisfied with the procedure. CONCLUSION: Home administration of misoprostol is safe and feasible for introduction into medical abortion services in India.
Authors: Jung Yeon Park; Hyo Jeong Ahn; Ba Raem Yoo; Kyu Ri Hwang; Taek Sang Lee; Hye Won Jeon; Sun Min Kim; Byoung Jae Kim Journal: Obstet Gynecol Sci Date: 2018-03-02